Has research found a cure for Alzheimer's diseace...
“has research found a cure for Alzheimer's diseace”
Summary
Research has not produced a cure for Alzheimer’s disease in humans. Recent studies show promising advances—such as reversal of disease in mouse models and early trial benefits—but no treatment has been proven to fully cure the condition. Claims of an existing cure are unfounded.
Sources 59 searched
- Alzheimer’s Drugs Are Finally Tackling the Disease Itself. Here’s How
Nature - While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 clinical trials, offer new hope.
- Controversial New Alzheimer’s Drugs Offer Hope—But at a High Cost | Nature
Drugs in this class, known as anti-amyloid therapies, have not gained much traction. In limited studies, they have been shown to slow or even decrease one of the biological symptoms of Alzheimer’s: the accumulation of amyloid beta in the brain. Nearly four dozen studies on these drugs have been conducted since 2018, and collectively they indicate that anti-amyloid therapies may marginally reduce the rate of cognitive decline.
- Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain: Cell Reports Medicine
Chaubey et al. demonstrate that restoration of brain resilience reverses advanced disease in two different mouse models of Alzheimer’s disease (AD), challenging the century-long dogma of AD irreversibility, and further identify potential therapeutic nodes in human AD brain.
- Treatment for Alzheimer's disease - The Lancet
Although these pharmacological and non-pharmacological strategies have significantly improved health outcomes for patients with Alzheimer's disease, many lack stringent evidence of efficacy.
- Alzheimer's disease drug development pipeline: 2026 - PubMed
Introduction: Discovery and development of new therapies for Alzheimer's disease (AD) are urgently needed to address the world's growing population of individuals on the AD pathophysiological continuum. Clinicaltrials.gov is a resource for studying drugs in development for treatment of AD. Results: There are currently 158 drugs in 192 AD trials.
- Alzheimer's Clinical Trial Results, Sadly Running True to Form | Science | AAAS
Studies of thousands of patients with early cognitive impairment who took an oral form of semaglutide (Rybelsus, currently approved as a diabetes therapy) did not show improvements in mental function as compared to placebo. The company says that the treatment group showed “improvement of Alzheimer’s disease-related biomarkers” in both trials, although it does not (as far as I can see) say what those biomarkers were.
- Article falsely claims Japanese Nobel winner cured Alzheimer's disease | Fact Check
There is no cure for Alzheimer's disease, despite claims online that Japanese doctor Yoshinori Ohsumi won a Nobel Prize for discovering a treatment for the neurodegenerative disease -- a protocol said to have helped acclaimed actor and director ...
- Promising early results from Alzheimer's trial targeting tau | UCL News
Professor Mummery commented: “The CELIA data provide some of the clearest evidence that reducing tau pathology can translate into clinically meaningful benefit. “The magnitude of tau reduction and cognitive benefit observed in CELIA is among the most compelling reported to date in Alzheimer’s disease drug development and supports advancing diranersen to Phase 3 development.”
- New study shows Alzheimer’s disease can be reversed to achieve full neurological recovery—not just prevented or slowed—in animal models | CWRU Newsroom | Case Western Reserve University
For more than a century, people have considered Alzheimer's disease (AD) an irreversible illness. Consequently, research has focused on preventing or slowing it, rather than recovery.